Naproxen sodium/Caffeine (BAY2880376)

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Pain, Postoperative

Drug Information

Target Indication

Pain, Postoperative

Clinical Trial

Last updated: 12/19/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals

EMA7/2/2009

Peyona (previously Nymusa)

Treatment of primary apnoea of premature newborns.

Drug Science

Mechanism of action & safety profile

Developer

BAYRY

BAYER

Related Pipeline

Superficial Vein Thrombosis

Polypoidal Choroidal Vasculopathy

Pelvic Inflammatory Disease

Pulmonary Tuberculosis

Severe Sepsis

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts